| The consensus molecular subtypes of colorectal cancer J Guinney, R Dienstmann, X Wang, A De Reynies, A Schlicker, ... Nature medicine 21 (11), 1350-1356, 2015 | 4672 | 2015 |
| Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer B Tran, S Kopetz, J Tie, P Gibbs, ZQ Jiang, CH Lieu, A Agarwal, DM Maru, ... Cancer 117 (20), 4623-4632, 2011 | 832 | 2011 |
| Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer S Kopetz, J Desai, E Chan, JR Hecht, PJ O'Dwyer, D Maru, V Morris, ... Journal of clinical oncology 33 (34), 4032-4038, 2015 | 739 | 2015 |
| Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases DG Blazer III, Y Kishi, DM Maru, S Kopetz, YS Chun, MJ Overman, ... Journal of Clinical Oncology 26 (33), 5344-5351, 2008 | 682 | 2008 |
| Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis Y Wang, DH Wiesnoski, BA Helmink, V Gopalakrishnan, K Choi, ... Nature medicine 24 (12), 1804-1808, 2018 | 588 | 2018 |
| Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases YS Chun, JN Vauthey, P Boonsirikamchai, DM Maru, S Kopetz, ... Jama 302 (21), 2338-2344, 2009 | 548 | 2009 |
| Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1 J Lu, X Ye, F Fan, L Xia, R Bhattacharya, S Bellister, F Tozzi, E Sceusi, ... Cancer cell 23 (2), 171-185, 2013 | 485 | 2013 |
| KRAS-IRF2 axis drives immune suppression and immune therapy resistance in colorectal cancer W Liao, MJ Overman, AT Boutin, X Shang, DI Zhao, P Dey, J Li, G Wang, ... Cancer cell 35 (4), 559-572. e7, 2019 | 439 | 2019 |
| RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases JN Vauthey, G Zimmitti, SE Kopetz, J Shindoh, SS Chen, A Andreou, ... Annals of surgery 258 (4), 619-627, 2013 | 384 | 2013 |
| Classifying colorectal cancer by tumor location rather than sidedness highlights a continuum in mutation profiles and consensus molecular subtypes JM Loree, AAL Pereira, M Lam, AN Willauer, K Raghav, A Dasari, ... Clinical Cancer Research 24 (5), 1062-1072, 2018 | 321 | 2018 |
| Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases Y Kishi, D Zorzi, CM Contreras, DM Maru, S Kopetz, D Ribero, M Motta, ... Annals of surgical oncology 17, 2870-2876, 2010 | 317 | 2010 |
| MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers R Luthra, RR Singh, MG Luthra, YX Li, C Hannah, AM Romans, ... Oncogene 27 (52), 6667-6678, 2008 | 317 | 2008 |
| Hippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like properties S Song, JA Ajani, S Honjo, DM Maru, Q Chen, AW Scott, TR Heallen, ... Cancer research 74 (15), 4170-4182, 2014 | 280 | 2014 |
| Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment MP Morelli, MJ Overman, A Dasari, SMA Kazmi, T Mazard, E Vilar, ... Annals of Oncology 26 (4), 731-736, 2015 | 275 | 2015 |
| Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer CH Crane, C Eng, BW Feig, P Das, JM Skibber, GJ Chang, RA Wolff, ... International Journal of Radiation Oncology* Biology* Physics 76 (3), 824-830, 2010 | 255 | 2010 |
| Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury MJ Overman, DM Maru, C Charnsangavej, EM Loyer, H Wang, P Pathak, ... Journal of Clinical Oncology 28 (15), 2549-2555, 2010 | 252 | 2010 |
| TP53 loss creates therapeutic vulnerability in colorectal cancer Y Liu, X Zhang, C Han, G Wan, X Huang, C Ivan, D Jiang, ... Nature 520 (7549), 697-701, 2015 | 245 | 2015 |
| Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy A Andreou, TA Aloia, A Brouquet, PV Dickson, G Zimmitti, DM Maru, ... Annals of surgery 257 (6), 1079-1088, 2013 | 235 | 2013 |
| Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study J Shindoh, X De Aretxabala, TA Aloia, JC Roa, I Roa, G Zimmitti, M Javle, ... Annals of surgery 261 (4), 733-739, 2015 | 234 | 2015 |
| Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases J Shindoh, EM Loyer, S Kopetz, P Boonsirikamchai, DM Maru, YS Chun, ... Journal of Clinical Oncology 30 (36), 4566-4572, 2012 | 228 | 2012 |
